EUVIMEDScopri EUVIMED
Übersichtsarbeit

The future of incretins in the treatment of obesity and non-alcoholic fatty liver disease

Christine R Andreasen, Andreas Andersen, Tina Vilsbøll

Diabetologia · 2023-10 · 66 (10) · 1846-1858

DOI: 10.1007/s00125-023-05966-9 ↗

At a glance

Übersichtsarbeit in Diabetologia, published online on 2023-07-27. Written by Christine R Andreasen and 2 co-authors. Institution: Clinical Research, Copenhagen University Hospital - Steno Diabetes Center Copenhagen, Herlev, Denmark. Major MEDLINE topics: Non-alcoholic Fatty Liver Disease, Diabetes Mellitus, Type 2. Cited 43 times so far (Crossref); 101 references.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Abstract non disponibile.

Subjects

MeSH terms (MEDLINE)

Non-alcoholic Fatty Liver DiseaseDiabetes Mellitus, Type 2HumansIncretinsGastric Inhibitory PolypeptideGlucagon-Like Peptide 1ObesityGlucagon-Like Peptide-1 Receptor Agonists

Author keywords

Glucagon-like peptide-1Glucose-dependent insulinotropic polypeptideIncretinsNon-alcoholic fatty liver diseaseObesityReview

Substances

IncretinsGastric Inhibitory PolypeptideGlucagon-Like Peptide 1Glucagon-Like Peptide-1 Receptor Agonists

Authors and institutions

  • Clinical Research, Copenhagen University Hospital - Steno Diabetes Center Copenhagen, Herlev, Denmark.
  • Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
  • Clinical Research, Copenhagen University Hospital - Steno Diabetes Center Copenhagen, Herlev, Denmark. t.vilsboll@dadlnet.dk.
  • Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. t.vilsboll@dadlnet.dk.
  • Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. t.vilsboll@dadlnet.dk.

Cite

APA

Andreasen, C. R., Andersen, A., & Vilsbøll, T. (2023). The future of incretins in the treatment of obesity and non-alcoholic fatty liver disease. Diabetologia, 66(10), 1846-1858. https://doi.org/10.1007/s00125-023-05966-9

Vancouver

Andreasen CR, Andersen A, Vilsbøll T. The future of incretins in the treatment of obesity and non-alcoholic fatty liver disease. Diabetologia. 2023;66(10):1846-1858. doi:10.1007/s00125-023-05966-9

BibTeX
@article{Andreasen2023,
  author = {Andreasen, Christine R and Andersen, Andreas and Vilsbøll, Tina},
  title = {The future of incretins in the treatment of obesity and non-alcoholic fatty liver disease},
  journal = {Diabetologia},
  year = {2023},
  volume = {66},
  number = {10},
  pages = {1846--1858},
  doi = {10.1007/s00125-023-05966-9}
}
Start for free →